Unilever is looking to sell or de-emphasize its food & beverage units as it eyes the consumer healthcare division of GlaxoSmithKline, whose products include Advil pain reliever and Aquafresh and Sensodyne toothpaste.
The latest bid was reported at $68 billion, which would require Unilever to raise cash, which may prompt it to sell off its remaining food & beverage portfolio.
Unilever’s food & beverage products include Ben & Jerry’s ice cream and Hellman’s mayonnaise.
According to Unilever, its strategic direction lies in materially expanding its health, beauty, and hygiene businesses, which would require major acquisitions accompanied by the accelerated divestment of lower-growth brands and businesses.
Unilever had sold parts of its food and beverage businesses recently, including its spreads portfolio in 2017 and most of its tea business in 2020.
According to Unilever CEO Alan Jope, while its food and refreshments products are still profitable, its long-term growth profile has been below other parts of its portfolio.


EUR/USD Eyes 1.17 as Fed Decision Could Weigh on Dollar
Zara Owner Inditex Sales Rise 9% in August
Asian Stocks Fall as Oil Tops $100, Yields Rise
OpenAI Targets Specialized Industries as Enterprise AI Demand Grows
Brent Oil Tops $100 as Middle East Conflict Threatens Supply
OpenAI Agents Linked to RubyGems Cyberattack
Gulf Ministers to Meet Iran in Oman Over Hormuz Shipping Deal
Japanese Yen Nears Seven-Month High as Oil Approaches $100
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
Norway Core Inflation Rises to 3% in August
Optus Apologises After Network Outage Disrupts Emergency Calls
SpaceX Nasdaq 100 Weight Set to More Than Double
Central Banks Could Buy 20,000 Tonnes of Gold: BofA
Boeing, SPEEA Reach Tentative Four-Year Labor Deal
TSMC August Revenue Jumps 53% on AI Chip Demand
TetherMax Expands into Asian Market Following Rebranding, Names Actor Yun Siyun as Brand Ambassador
Enflame Shares Surge 200% in Shanghai AI Chip Debut 



